World Professional Association for Transgender Health v. FTC

Current understanding

On July 10, 2026, Chief Judge James E. Boasberg of the U.S. District Court for the District of Columbia issued an opinion in World Professional Association for Transgender Health v. Federal Trade Commission, a dispute concerning FTC engagement with transgender healthcare practices associated with WPATH’s clinical guidelines. The available abstract does not yet make clear the specific holding, scope of relief, or which claims survived; the practical effect on clinicians who rely on WPATH Standards of Care and on transgender patients seeking gender-affirming care remains to be characterized as the opinion is analyzed.

Evidence log

• 2026-07-10 — World Professional Association for Transgender Health v. Federal Trade Commission: cross-connection with lgbtq-transgender-rights: The WPATH–FTC opinion is a direct data point on federal regulatory posture toward transgender healthcare providers and clinical guidelines. (novelty: 3)

Open questions

Related